BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohammed I, Said DG, Dua HS. Human antimicrobial peptides in ocular surface defense. Progress in Retinal and Eye Research 2017;61:1-22. [DOI: 10.1016/j.preteyeres.2017.03.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Dua HS, Said DG, Messmer EM, Rolando M, Benitez-del-castillo JM, Hossain PN, Shortt AJ, Geerling G, Nubile M, Figueiredo FC, Rauz S, Mastropasqua L, Rama P, Baudouin C. Neurotrophic keratopathy. Progress in Retinal and Eye Research 2018;66:107-31. [DOI: 10.1016/j.preteyeres.2018.04.003] [Cited by in Crossref: 112] [Cited by in F6Publishing: 91] [Article Influence: 28.0] [Reference Citation Analysis]
2 Gökçınar NB, Karabulut AA, Onaran Z, Yumuşak E, Budak Yıldıran FA. Elevated Tear Human Neutrophil Peptides 1-3, Human Beta Defensin-2 Levels and Conjunctival Cathelicidin LL-37 Gene Expression in Ocular Rosacea. Ocul Immunol Inflamm 2019;27:1174-83. [PMID: 30142005 DOI: 10.1080/09273948.2018.1504971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shoji J. Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases. Allergol Int 2020;69:496-504. [PMID: 32563624 DOI: 10.1016/j.alit.2020.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mohammed I, Kulkarni B, Faraj LA, Abbas A, Dua HS, King AJ. Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study. Clin Exp Ophthalmol 2020;48:973-82. [PMID: 32564453 DOI: 10.1111/ceo.13814] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zhan X, Li J, Guo Y, Golubnitschaja O. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine. EPMA J 2021;:1-27. [PMID: 34876936 DOI: 10.1007/s13167-021-00265-y] [Reference Citation Analysis]
6 Jadi PK, Sharma P, Bhogapurapu B, Roy S. Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis. Front Chem 2021;9:694998. [PMID: 34458234 DOI: 10.3389/fchem.2021.694998] [Reference Citation Analysis]
7 Ung L, Chodosh J. Foundational concepts in the biology of bacterial keratitis. Exp Eye Res 2021;209:108647. [PMID: 34097906 DOI: 10.1016/j.exer.2021.108647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nishida T, Sugioka K, Fukuda K, Murakami J. Pivotal Role of Corneal Fibroblasts in Progression to Corneal Ulcer in Bacterial Keratitis. Int J Mol Sci 2021;22:8979. [PMID: 34445684 DOI: 10.3390/ijms22168979] [Reference Citation Analysis]
9 Luong HX, Thanh TT, Tran TH. Antimicrobial peptides - Advances in development of therapeutic applications. Life Sci 2020;260:118407. [PMID: 32931796 DOI: 10.1016/j.lfs.2020.118407] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
10 Eshac Y, Redfern RL, Aakalu VK. The Role of Endogenous Antimicrobial Peptides in Modulating Innate Immunity of the Ocular Surface in Dry Eye Diseases. Int J Mol Sci 2021;22:E721. [PMID: 33450870 DOI: 10.3390/ijms22020721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang QY, Yan ZB, Meng YM, Hong XY, Shao G, Ma JJ, Cheng XR, Liu J, Kang J, Fu CY. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res 2021;8:48. [PMID: 34496967 DOI: 10.1186/s40779-021-00343-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mohammed I, Mohanty D, Said DG, Barik MR, Reddy MM, Alsaadi A, Das S, Dua HS, Mittal R. Antimicrobial peptides in human corneal tissue of patients with fungal keratitis. Br J Ophthalmol 2021;105:1172-7. [PMID: 32855162 DOI: 10.1136/bjophthalmol-2020-316329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Singh RB, Das S, Chodosh J, Sharma N, Zegans ME, Kowalski RP, Jhanji V. Paradox of complex diversity: Challenges in the diagnosis and management of bacterial keratitis. Prog Retin Eye Res 2021;:101028. [PMID: 34813978 DOI: 10.1016/j.preteyeres.2021.101028] [Reference Citation Analysis]
14 Hazlett LD, Xu S, Somayajulu M, McClellan SA. Host-microbe interactions in cornea. Ocul Surf 2021:S1542-0124(21)00113-0. [PMID: 34619389 DOI: 10.1016/j.jtos.2021.09.008] [Reference Citation Analysis]
15 Wan SJ, Datta A, Flandrin O, Metruccio MME, Ma S, Nieto V, Kroken AR, Hill RZ, Bautista DM, Evans DJ, Fleiszig SMJ. Nerve-associated transient receptor potential ion channels can contribute to intrinsic resistance to bacterial adhesion in vivo. FASEB J 2021;35:e21899. [PMID: 34569661 DOI: 10.1096/fj.202100874R] [Reference Citation Analysis]
16 Ting DSJ, Beuerman RW, Dua HS, Lakshminarayanan R, Mohammed I. Strategies in Translating the Therapeutic Potentials of Host Defense Peptides. Front Immunol 2020;11:983. [PMID: 32528474 DOI: 10.3389/fimmu.2020.00983] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
17 Liu J, Li Z. Resident Innate Immune Cells in the Cornea. Front Immunol 2021;12:620284. [PMID: 33717118 DOI: 10.3389/fimmu.2021.620284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ting DSJ, Li J, Verma CS, Goh ETL, Nubile M, Mastropasqua L, Said DG, Beuerman RW, Lakshminarayanan R, Mohammed I, Dua HS. Evaluation of Host Defense Peptide (CaD23)-Antibiotic Interaction and Mechanism of Action: Insights From Experimental and Molecular Dynamics Simulations Studies. Front Pharmacol 2021;12:731499. [PMID: 34690770 DOI: 10.3389/fphar.2021.731499] [Reference Citation Analysis]
19 Song A, Deshmukh R, Lin H, Ang M, Mehta JS, Chodosh J, Said DG, Dua HS, Ting DSJ. Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes. Front Med (Lausanne) 2021;8:707242. [PMID: 34307431 DOI: 10.3389/fmed.2021.707242] [Reference Citation Analysis]
20 Mills B, Radhakrishnan N, Karthikeyan Rajapandian SG, Rameshkumar G, Lalitha P, Prajna NV. The role of fungi in fungal keratitis. Exp Eye Res 2021;202:108372. [PMID: 33249061 DOI: 10.1016/j.exer.2020.108372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Thuret G, Courrier E, Poinard S, Gain P, Baud'Huin M, Martinache I, Cursiefen C, Maier P, Hjortdal J, Sanchez Ibanez J, Ponzin D, Ferrari S, Jones G, Griffoni C, Rooney P, Bennett K, Armitage WJ, Figueiredo F, Nuijts R, Dickman M. One threat, different answers: the impact of COVID-19 pandemic on cornea donation and donor selection across Europe. Br J Ophthalmol 2020:bjophthalmol-2020-317938. [PMID: 33243832 DOI: 10.1136/bjophthalmol-2020-317938] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
22 Mohammed I, Said DG, Nubile M, Mastropasqua L, Dua HS. Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa. Front Microbiol 2019;10:2190. [PMID: 31608030 DOI: 10.3389/fmicb.2019.02190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
23 Ting DSJ, Goh ETL, Mayandi V, Busoy JMF, Aung TT, Periayah MH, Nubile M, Mastropasqua L, Said DG, Htoon HM, Barathi VA, Beuerman RW, Lakshminarayanan R, Mohammed I, Dua HS. Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis. Sci Rep 2021;11:18304. [PMID: 34526600 DOI: 10.1038/s41598-021-97821-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Niu L, Liu X, Ma Z, Yin Y, Sun L, Yang L, Zheng Y. Fungal keratitis: Pathogenesis, diagnosis and prevention. Microb Pathog 2020;138:103802. [PMID: 31626916 DOI: 10.1016/j.micpath.2019.103802] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
25 Sánchez-Cruz A, Méndez AC, Lizasoain I, de la Villa P, de la Rosa EJ, Hernández-Sánchez C. Tlr2 Gene Deletion Delays Retinal Degeneration in Two Genetically Distinct Mouse Models of Retinitis Pigmentosa. Int J Mol Sci 2021;22:7815. [PMID: 34360582 DOI: 10.3390/ijms22157815] [Reference Citation Analysis]
26 Fleiszig SMJ, Kroken AR, Nieto V, Grosser MR, Wan SJ, Metruccio MME, Evans DJ. Contact lens-related corneal infection: Intrinsic resistance and its compromise. Prog Retin Eye Res 2020;76:100804. [PMID: 31756497 DOI: 10.1016/j.preteyeres.2019.100804] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
27 Hosny AES, El-Bazza ZE, Ramadan MA, Shafik MA, Shafeek MA, Khattab RA. Expression levels of pro-inflammatory interleukin-8 and certain antimicrobial peptides in concurrent with bacterial conjunctivitis. Int J Ophthalmol 2021;14:666-75. [PMID: 34012880 DOI: 10.18240/ijo.2021.05.05] [Reference Citation Analysis]
28 Cui Z, Luo Q, Bannon MS, Gray VP, Bloom TG, Clore MF, Hughes MA, Crawford MA, Letteri RA. Molecular engineering of antimicrobial peptide (AMP)-polymer conjugates. Biomater Sci 2021;9:5069-91. [PMID: 34096936 DOI: 10.1039/d1bm00423a] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Fukuda K, Ishida W, Fukushima A, Nishida T. Corneal Fibroblasts as Sentinel Cells and Local Immune Modulators in Infectious Keratitis. Int J Mol Sci 2017;18:E1831. [PMID: 28832498 DOI: 10.3390/ijms18091831] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
30 Huan Y, Peng XD, Lin J, Zhang YX, Zhan L, Gao H, Zhao GQ. Anti-inflammatory effects of astaxanthin against fungal keratitis. Int J Ophthalmol 2020;13:1681-8. [PMID: 33214996 DOI: 10.18240/ijo.2020.11.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]